[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bastiaan  van der Baan M.Sc.", "age": 52, "title": "President, CEO & Chairman of the Board of Directors", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 172784, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Neal Weingarten", "age": 72, "title": "CFO, VP & Secretary", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 175000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Johannes Henricus Matthias Schellens M.D., Ph.D.", "age": 67, "title": "Consultant & Chief Medical Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.26, "open": 1.21, "dayLow": 1.21, "dayHigh": 1.23, "regularMarketPreviousClose": 1.26, "regularMarketOpen": 1.21, "regularMarketDayLow": 1.21, "regularMarketDayHigh": 1.23, "payoutRatio": 0.0, "beta": 0.396, "volume": 1984, "regularMarketVolume": 1984, "averageVolume": 64254, "averageVolume10days": 7090, "averageDailyVolume10Day": 7090, "bid": 0.0, "ask": 2.4, "bidSize": 0, "askSize": 1, "marketCap": 3287985, "fiftyTwoWeekLow": 1.02, "fiftyTwoWeekHigh": 3.5, "fiftyDayAverage": 1.2274, "twoHundredDayAverage": 1.8049, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 5601414, "profitMargins": 0.0, "floatShares": 2523701, "sharesOutstanding": 2684070, "sharesShort": 26526, "sharesShortPriorMonth": 53607, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0099, "heldPercentInsiders": 0.18431999, "heldPercentInstitutions": 0.18281999, "shortRatio": 1.16, "shortPercentOfFloat": 0.01, "impliedSharesOutstanding": 2684070, "bookValue": -1.188, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -3585965, "trailingEps": -1.59, "lastSplitFactor": "1:10", "lastSplitDate": 1685923200, "52WeekChange": -0.56985295, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 1.225, "recommendationKey": "none", "totalCash": 1038952, "totalCashPerShare": 0.387, "totalDebt": 0, "quickRatio": 3.264, "currentRatio": 3.599, "returnOnAssets": -0.81883, "returnOnEquity": -1.48734, "freeCashflow": -1822077, "operatingCashflow": -3164536, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LIXT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1193319000000, "fiftyTwoWeekLowChange": 0.20500004, "fiftyTwoWeekLowChangePercent": 0.20098044, "fiftyTwoWeekRange": "1.02 - 3.5", "fiftyTwoWeekHighChange": -2.275, "fiftyTwoWeekHighChangePercent": -0.65000004, "fiftyTwoWeekChangePercent": -56.985294, "dividendDate": 1605830400, "earningsTimestamp": 1742819400, "regularMarketChange": -0.034999967, "regularMarketDayRange": "1.21 - 1.23", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 64254, "shortName": "Lixte Biotechnology Holdings, I", "longName": "Lixte Biotechnology Holdings, Inc.", "earningsTimestampStart": 1746707400, "earningsTimestampEnd": 1747053000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.59, "fiftyDayAverageChange": -0.0023999214, "fiftyDayAverageChangePercent": -0.001955289, "twoHundredDayAverageChange": -0.5799, "twoHundredDayAverageChangePercent": -0.32129204, "priceToBook": -1.0311449, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1746721993, "exchange": "NCM", "messageBoardId": "finmb_29181356", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.777775, "regularMarketPrice": 1.225, "marketState": "REGULAR", "displayName": "Lixte Biotechnology", "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]